Hm2 cDNA from maize encoding disease resistance polypeptide
US6211440A · kind A · utility
6Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 14, 1999 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Jan 14, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/8282
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides isolated Hm2 nucleic acids. The invention further provides expression cassettes, transferred host cells, and transgenic plants. Also, the invention provides methods of imparting disease resistance to plants susceptible to fungal pathogens, which utilize cyclic tetrapeptide toxins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.